EGFR and lung adenocarcinoma: In conclusion, our preliminary findings in a small patient population indicated that FDG PET texture indices may be potential imaging biomarkers for the EGFR mutation status in patients with newly diagnosed lung adenocarcinoma, although the mechanism and biological significance remain unclear.